18F-PSMA PET/CT Versus CT Alone in Assessment of Prostatic Cancer Patients
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
AgeNot listed
SponsorAssiut University
About this trial
To compare the diagnostic performance of 18-F PSMA PET/CT and CT alone in initial staging, assessment of therapy response, as well as evaluation of biochemical recurrence of prostatic cancer patients
The main question it aims to answer is:
Does 18-F PSMA PET/CT have a superior role over CT in evaluation of prostatic cancer patients?
Eligibility criteria
Qualifiers
None
Disqualifiers
Patients with claustrophobia
Patients refuse to do the scan
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov